Factor IX pharmacokinetics: differences between plasma-derived and recombinant products and the clinical and economic implications: a meeting report.
Morfini
M
M
Agency for Hemophilia, Azienda Ospedaliero Universitaria Careggi, Viale G.B. Morgagni n.85, Florence, Italy. m.morfini@dfc.unifi.it
Laguna
P
P
Leissinger
C
C
D000328:Adult; D016527:Drug Costs / Q000706:statistics & numerical data; D005164:Factor IX / Q000191:economics / Q000493:pharmacokinetics*; D002836:Hemophilia B / Q000097:blood* / Q000191:economics; D006801:Humans; D008297:Male; D011994:Recombinant Proteins / Q000097:blood / Q000191:economics
D011994:Recombinant Proteins; D005164:Factor IX